Laurent Van Lerberghe
- Sep 11
- 2 min
60
4
million € sales
170 k
people impacted
partnerships with world class players
5
01
Cutting-edge services including AI-based Discovery, Decentralized Clinical Trials, innovative CDMO solutions like Cell & Gene Therapy, and pioneering Digital Therapeutics.
AI in drug discovery / Decentralised trials
02
We focus on transformative investments in healthcare, encompassing Acute Care in hospitals, Treatment Initiation & Observance, Chronic Treatment innovations, and initiatives for Quality Aging, aiming to elevate patient care and outcomes across all stages of life.
Acute care, Chronic care
03
Our investment strategy targets the forefront of medical technology, including AI-based diagnostics, advanced AI imaging, Digital MedTech innovations, and the pioneering field of Predictive Medicine, all designed to revolutionize patient care and health outcomes.
AI imaging, Digital MedTech
01
Invest in teams aligned with our vision and purpose
Foster a movement rooted in our respective countries
Aim to scale operations across Europe
02
Advocate for spreading new models through widespread access to AI, tech knowledge, and STEM studies
Fund scholarships and enable student access to the ecosystem
03
Value diversity among entrepreneurs and startups for enhanced growth
Commit to maintaining gender balance in investment decisions
04
Share a vision for healthcare innovation that revolutionises current models
Support entrepreneurs that invent rather than optimise
MBA Insead, Commercial Engineer
Former Chief Strategy Officer Sanofi
& VP Commercial Abbott
Healthcare C-Suite Executive
Investor in Digital Health